logo
welcome
ScienceDaily

ScienceDaily

Precision oncology via artificial intelligence on cancer biopsies

ScienceDaily
Summary
Nutrition label

81% Informative

A new AI protocol bypasses genomic sequencing and promises access and equity in cancer care.

A paper describing the new AI method for examining routine biopsies, called DeepHRD, was recently published in the Journal of Clinical Oncology .

The new method is designed to save weeks and thousands of dollars from clinical oncology treatment workflows for breast and ovarian cancers.

The AI technology behind DeepHRD is protected by provisional patents through UC San Diego .

The goal is to move this AI platform into the clinical arena as quickly as possible to make precision therapy real for patients with cancer.

The authors expect that the same technology could be applied to most other genomic biomarkers and many forms of cancer.

VR Score

91

Informative language

97

Neutral language

62

Article tone

formal

Language

English

Language complexity

81

Offensive language

not offensive

Hate speech

not hateful

Attention-grabbing headline

not detected

Known propaganda techniques

not detected

Time-value

long-living

External references

no external sources

Source diversity

no sources

Affiliate links

no affiliate links